In conclusion, our study reports a novel target of DsbA-L and demonstrates that DsbA-L could exacerbate BLM-induced PF through the regulation of TGF-β1 and/SMAD3 signaling and macrophage polarization, providing clues for exploring potential drugs for the treatment of PF. The gene discussed is TGFB1; the disease is Bloom syndrome.